Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,349-9,360 of 10,661

Drug study icon

CompletedNCT01511510

Safety study of Repeated Doses of PF-04958242 in Schizophrenia

This study is completed in the United States. It is testing Repeated Doses of PF-04958242 for Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Biogen
Condition: Schizophrenia

Drug study icon

CompletedNCT02228395

Safety study of Single Doses Of PF-04958242 in Schizophrenia

This study is completed in the United States. It is testing Single Doses Of PF-04958242 for Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Biogen
Condition: Schizophrenia

Drug study icon

CompletedNCT05686408

TNX-601 ER Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)

This study is completed in the United States. It is testing TNX-601 ER Monotherapy for depression.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Tonix Pharmaceuticals, Inc.
Condition: Depression

Device study icon

CompletedNCT05535062

Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature

This study is completed in the United States. It focuses on Depression.

In United States

DepressionDeviceFrom 22 Years to 70 Years

Countries: United States
Sponsor: Neuronetics
Condition: Depression

Drug study icon

CompletedNCT03503318

TV-46000 for schizophrenia

This study is completed in the United States and in Bulgaria. It is testing TV-46000 for schizophrenia.

In United States

SchizophreniaDrugFrom 13 Years to 65 Years

Countries: United States, Bulgaria
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT01012375

Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: ADHD

Drug study icon

CompletedNCT00535132

Study to Measure Drug Satisfaction of people with Schizophrenia After Switching From Risperidone to Paliperidone

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States, Argentina, Colombia, ...
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition: Schizophrenia

Drug study icon

CompletedNCT00535145

Study to Measure the Safety of Paliperidone ER (Extended-release) in people with Liver Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02738944

Study to Promote Innovation in Rural Integrated Telepsychiatry

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, BipolarityBehavioralOver 18 Years

Countries: United States
Sponsor: University of Washington
Condition: PTSD, Bipolarity

Drug study icon

CompletedNCT01311778

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Hurd,Yasmin, Ph.D.
Condition: Addiction

Behavioral study icon

CompletedNCT01299909

Study Two on the Effectiveness of Mindfulness Training for Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Wisconsin, Madison
Condition: Addiction

Behavioral study icon

CompletedNCT01409096

Study Using Pregnenolone to Treat Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.